NCT06632509 is a clinical trial of BD SiteRite(TM) 9 in BD SiteRite 9 for VAD Insertion, sponsored by Becton, Dickinson and Company.

Who is sponsoring NCT06632509?

NCT06632509 is sponsored by Becton, Dickinson and Company.

What drugs are being tested in NCT06632509?

Interventions in NCT06632509: BD SiteRite(TM) 9.

What condition does NCT06632509 study?

NCT06632509 studies BD SiteRite 9 for VAD Insertion.

Is NCT06632509 still recruiting?

NCT06632509 is currently completed. Last updated 15 January 2026.

Last reviewed 2026-01-15 · How we verify

NCT06632509

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BD SiteRite(TM) 9 Ultrasound System - Clinical Study

Completed Last updated 15 January 2026

What this trial tests

trial testing BD SiteRite(TM) 9 in BD SiteRite 9 for VAD Insertion in 149 participants. Completed in 9 January 2026.

Timeline

12 November 2025

Primary endpoint
9 January 2026

9 January 2026

Quick facts

Lead sponsor	Becton, Dickinson and Company
Status	Completed
Study type	OBSERVATIONAL
Enrollment	149
Start date	12 November 2025
Primary completion	9 January 2026
Estimated completion	9 January 2026
Sites	1 location across United States

Drugs / interventions tested

BD SiteRite(TM) 9

Conditions studied

BD SiteRite 9 for VAD Insertion — all drugs for BD SiteRite 9 for VAD Insertion →

Sponsor

Becton, Dickinson and Company — full company profile →

Who can join

1 and older, any sex, with BD SiteRite 9 for VAD Insertion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This post-market study is being conducted to generate safety and performance data on the SiteRite 9 System. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Becton, Dickinson and Company trials

Trials by the same sponsor.

NCT06632496 — BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study · completed
NCT06604026 — Investigational Study With the BD PosiFlush™ SafeScrub on NADs · NA · recruiting
NCT06426121 — Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product · completed
NCT05953363 — Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories. · completed
NCT05763147 — Study of BD Pre-filled Flush Syringes in China · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06632509 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Becton, Dickinson and Company
Last refreshed: 15 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06632509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing